6
38
S. Caddick et al. / Journal of Organometallic Chemistry 617–618 (2001) 635–639
−
3
through a column of basic alumina prior to use. Potas-
u(Mo–K )=0.71073 A
,
, Z=4, Dcalc=1.51 Mg m
,
a
−
1
sium tert-butoxide was purchased from Aldrich and
v(Mo–K )=1.27 mm , T=173 K. Data was col-
a
−
5
sublimed twice at 157°C, 1×10
dioxane was purchased from Aldrich and stored in an
ampoule under argon over 4 A molecular sieves.
mbar. Anhydrous
lected on an Enraf-Nonius CAD4 diffractometer using
a crystal of dimensions 0.3×0.3×0.2 mm. A total of
4832 unique reflections were measured of which 4067
had ꢀF ꢀ\2|(F ). The final residuals were R =0.045
,
¸
¹¹¹¹¹¹¹º
t
t
3
2
2
[
CN( Bu)(CH) N( Bu)] [7] and [(Pd(h -C H )Cl) ] [21]
2
4
7
2
1
were synthesised according to literature procedures.
(for I\2|(I)) and wR =0.121 for all data.
2
For a procedure for the synthesis of (Z)-ethyl-2-
bromo-3-iodopropenoate, its coupling with trimethyl-
silylacteylene and for characterisation data for (Z)-
5
.1. Synthesis of bis(1,3-di-tert-butylimidazol-2-
¸¹¹¹¹¹¹¹º
t
t
ylidene)palladium(0) [Pd{CN( Bu)(CH) N( Bu)} ] (1)
ethyl-2-bromo-3-iodopropenoate
and
(Z)-ethyl-2-
2
2
bromo-3-ethynyl-(trimethylsilyl)propenoate (3) see
Refs. [16,17].
¸
¹¹¹¹¹¹¹º
t
t
3
[
CN( Bu)(CH) N( Bu)] (183 mg, 1.02 mmol), [(Pd(h -
2
C H )Cl) ] (100 mg, 0.254 mmol) and sodium dimethyl-
4
7
2
malonate (78 mg, 0.506 mmol) were placed in an
ampoule equipped with a Rotaflo stopcock and THF
added (30 ml). The mixture was heated at 90°C for 16
h with stirring after which the solution was brown.
After cooling to room temperature, the mixture was
filtered from some free palladium metal and the solu-
tion concentrated. Crystallisation at −50°C yielded the
product as a yellow solid in 60% yield (143 mg).
5.3. Coupling of p-chlorotoluene with morpholine and
piperidine
5.3.1. General procedure
The catalyst (7.4 mg, 0.16 mmol) and KO Bu (133
t
mg, 1.19 mmol) were weighed into a tube in a glovebox
and capped with a septum. Dioxane (5 ml) was added.
Chlorotoluene (100 mg, 0.79 mmol) followed by the
amine (0.95 mmol) were injected into the tube. The
mixture was heated at 100°C for 16 h. The product was
purified by absorption of the crude reaction mixture
onto silica followed by flash chromatography eluting
with a solvent gradient starting with hexane and finish-
ing with 5% EtOAc–hexane.
Elemental analysis. Anal. Found: C, 56.67; H, 8.54;
N, 12.22. Calc. for [C H N Pd]: C, 56.58; H, 8.63; N,
2
2
40
4
1
2.00%.
1
H-NMR (C D ): l 2.12 (18H, s, NC(CH
6
3)3), 6.74
6
6
13
1
(
2H, s, NCH
NC(CH ) ), 57.35 (s, N C6 (CH ) ), 113.95 (s, N C6 C).
3 3
6 CH6 N). C{ H}-NMR (C D ): l 31.96 (s,
6
6
6
3
3
5
.2. Synthesis of chloro(1,3-di-tert-butylimidazol-2-
The respective coupling products were found to be
identical by H-NMR with literature data for 1-(4-
methylphenyl)piperidine [22] and 1-(4-methylphenyl)-
morpholine [23].
3
1
ylidene)(methylallyl)palladium(II) [Pd(p -C H )-
¸
¹¹¹¹¹¹¹º
4
7
t
t
{(CN( Bu)(CH) N( Bu)}Cl] (2)
2
3
To a Schlenk tube containing [(Pd(h -C H )Cl) ] (260
¸
¹¹¹¹¹¹¹º
4
7
2
t
t
mg, 0.66 mmol) and [CN( Bu)(CH) N( Bu)] (237 mg,
2
1.32 mmol) toluene (20 ml) was added. The solids
dissolved to give an orange solution. The solution was
concentrated and the product crystallised at ambient
6. Supplementary material
temperature in 90% yield.
Crystallographic data for the structures reported in
this paper have been deposited with the Cambridge
Crystallographic Data Centre, CCDC no. 148362 for
complex 2. Copies of this information may be obtained
free of charge from the Director, CCDC, 12 Union
Road, Cambridge, CB2 1EZ, UK (fax: +44-1223-
336033; e-mail: deposit@ccdc.cam.ac.uk or http://
www.ccdc.cam.ac.uk).
1
H-NMR (C D ): l 1.55 (s, 9H, NC(CH
6
3)3), 1.69 (s,
6
6
9
1
1
H, NC(CH
6
) ), 1.71 (s, 3H, CH CCH
6
CH ), 2.15 (s,
3
3
2
3
2
H, broad), 3.05 (m, 1H), 3.24 (s, 1H, broad), 4.07 (m,
1
3
1
H) (CH
6
CCH CH ), 6.69 (m, 2H, NCCH
6
6
). C{ H}-
2
3
2
NMR (C D ): l 22.73 (s, CH CC
6 H CH ) 31.73 (s,
H ) ), 52.04 (s,
(CH ) ), 58.53 (s,
6
6
2
3
2
NC(C
6
H ) ), 31.99 (s, NC(C
6
3
3
3 3
CH CCH C
6
H2), 57.96 (s, NC
6
2
3
3 3
NC
NCC
6 (CH ) ), 67.91 (s, CH CCH C6 H2), 118.06 (s,
3 3 2 3
6
H), 118.12 (s, NC
6 CH), 127.29 (s, CH C6 CH CH ),
2 3 2
+
1
M
78 (s, NC
6
N). EI MS: m/z 378 (33%, M ), 341 (7%,
+
+
+
–Cl), 286 (100%, M –C H and Cl), 229 (93%,
Acknowledgements
4
7
t
M -C H , Cl and Bu). C H ClN Pd (378): Calc.: C,
4
7
15 27
2
4
7.87, H, 7.18, N, 7.45. Anal. Found: C, 47.72, H, 6.95,
The authors thank the EPSRC and AstraZeneca for
financial support and are grateful to Dr. A. Abdul-Sada
for recording the mass spectra and to Dr. A. Avent for
recording NMR spectra.
N, 7.52. Crystal data: C H ClN Pd, monoclinic, FW
3
9
15
27
2
77.24, space group P2 /c (no. 14); a=10.951(4), b=
1
3
.987(4), c=15.400(6) A, i=98.8°, U=1664(1) A ,
, ,